Skip to main content
. 2022 Aug 9;13:941251. doi: 10.3389/fneur.2022.941251

Table 4.

Comparison of clinical characteristics and NLR in patients presented 90 death or not.

IVT MT
Yes (n = 34) No (n = 542) Statistic value p Yes (n = 80) No (n = 271) Statistic value p
Admission NIHSS, median (IQR) 15 (12–17) 5 (2–10) −10.5 <0.001* 19 (12–24) 14 (10–17) −2.7 0.007*
Age, median (IQR) 81 (72–88) 68 (58–76) −5.5 <0.001* 72 (63–79) 68 (59–76) −5.0 <0.001*
Male, n (%) 16 (47) 363 (67) 5.6 0.02* 59 (73) 190 (70) 0.4 0.5
Hypertension, n (%) 25 (73) 392 (72) 0.02 0.9 57 (71) 190 (70) 0.04 0.84
Diabetes mellitus, n (%) 11 (32) 162 (29) 0.1 0.8 31 (38) 70 (25) 5 0.03*
Hyperlipidemia, n (%) 6 (18) 41 (8) 0.6 0.4 12 (15) 27 (10) 2.3 0.1
Atrial fibrillation, n (%) 16 (47) 148 (27) 6.1 0.01* 31 (38) 125 (46) 1.4 0.4
Current smoker, n (%) 9 (26) 136 (25) 0.03 0.8 1 (1) 6 (2) 0.3 0.6
Stroke history, n (%) 2 (5) 36 (7) 0.03 0.8 11 (14) 44 (16) 0.3 0.6
mRS 0–1 before stroke, n (%) 31 (91) 518 (95) 1.3 0.2 72 (90) 238 (88) 0.3 0.6
Admission NLR, median (IQR) 3.8 (1.9–5.7) 2.5 (1.6–4.3) −1.7 0.09 4.5 (2.7–8.9) 4.2 (2.5–6.4) −1.7 0.09
Day 1 NLR, median (IQR) 8.6 (5.5–12.9) 3.3 (2.3–5.4) −6 <0.001* 7.1 (4.1–10.1) 5.5 (3.8–8.4) −2.2 0.03*
Day 1 NHISS, median (IQR) 26 (19–30) 3 (1–7) −9.4 <0.001* 29 (27–32) 10 (5–14) −13.2 <0.001*
Stroke onset to treat time, min, median (IQR) 167 (122–179) 162 (119–183) −1.2 0.16 323 (267–364) 319 (271–347) −1.1 0.21
Stroke etiology (TOAST), n (%)
Large-artery atherosclerosis 24 (71) 349 (64) 0.5 0.5 37 (46) 147 (54) 0.2 0.7
Cardioembolism 7 (20) 121 (22) 0.05 0.8 35 (44) 121 (45) 0.1 0.6
Other 5 (15) 70 (13) 0.02 0.9 8 (10) 3 (1) 0.002 0.9
Anterior circulation, n (%) 27 (79) 470 (87) 1.4 0.2 71 (89) 226 (83) 1.4 0.2

IVT, intravenous thrombolysis; MT, mechanical thrombectomy; NIHSS, National Institutes of Health Stroke Scale; IQR, interquartile range; NLR, neutrophil over lymphocytes ratio.

*

Statistically significant.